Cofactor Genomics

Cofactor Genomics is a company focused on predictive immune modeling. They aim to advance precision medicine by overcoming existing barriers. Cofactor facilitates the shift from single-analyte biomarkers to more comprehensive multidimensional biomarkers using health expression models. Their capabilities include molecular, informatic, and database tools, with one of the first CAP-certified clinical RNA sequencing laboratories. This certification helps their partners conduct clinical trials more efficiently and cost-effectively. Their expertise in molecular biology, informatics, and database management enables them to provide high-quality services to the healthcare and pharmaceutical sectors, contributing to medical research and improving patient outcomes.

David Messina Ph.D

Co-Founder and COO

1 past transactions

Narus Biotechnologies

Acquisition in 2016
Narus Biotechnologies uses cell free RNA to monitor neurodegeneration. It develops novel molecular diagnostics for cancer and neurological disease. Narus Biotechnologies is a U.S.-based company that was founded in 2015 by Raman Talwar and Ryan Bloom. The company was acquired by Cofactor Genomics on February 4, 2016.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.